Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Cinchona alkaloid used in the prophylaxis and treatment of malaria (Pérez 2009).
Administered orally or intravenously.
It is excreted in breast milk in clinically insignificant amounts (Mathew 2004, Phillips 1986, Terwilliger 1934), much lower than the dose used in newborns and infants (Fulton 1992).
No problems have been observed in infants whose mothers were taking it (FDA 2008, Terwilliger 1934).
Its use is authorized in infants and children.
Avoid in cases of glucose-6-phosphate dehydrogenase deficiency (Mathew 2004, WHO/UNICEF 2002, Fulton 1992).
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
WHO list of essential medicines: compatible with breastfeeding (WHO / UNICEF, 2002).